CD8A and neoplasm: In addition, the favorable clinical efficacy of ICIs is also associated with positive PD-L1 expression and CD8+ T cell infiltration in the tumor tissue, as sufficient CD8+ TILs in the TME is the foundation of anti-tumor effect activated by ICIs (36).